Home DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on...
 

Keywords :   


DelMar Pharmaceuticals Presents Updated Phase I/II Clinical Data on...

2015-09-10 15:12:57| Logistics - Topix.net

DelMar Pharmaceuticals, Inc. , a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today presented updated clinical data from its Phase I/II study of lead product candidate VAL-083 , in patients with refractory glioblastoma multiforme , at GBM2015 : 2 International Symposium on Clinical and Basic Investigation in Glioblastoma in Toledo, Spain. The Company's data was presented in a poster entitled, "Update on Phase I/II study of VAL-083 in patients with recurrent malignant glioma."

Tags: data updated iii phase

Category:Transportation and Logistics

Latest from this category

All news

»
29.03Chinese smartphone giant takes on Tesla
29.03Questions raised over Temu cash 'giveaway' offer
29.03Charge of 90 to clear problem debt axed for poorest
29.03India's army of gold refiners face new competition
28.03Amorepacific Patents Hair Growth Compositions with Camellia Kaempferol Glycoside
28.03Dry Shampoo That Provides Color Patented by Church & Dwight
28.03FTX's Sam Bankman-Fried sentenced to 25 years
28.03Pork producers donate 35,000 pounds of Dailys bacon to Utah Food Bank
More »